[1]Ibeh N, Okocha CE, Aneke CJ, Onah CE, Nwosu AO, Nkwazema KA. Normal pregnancy and coagulation profile: from the first through the third trimester. Nigerian journal of medicine: journal of the National Association of Resident Doctors of Nigeria.2015;24(1): 54–7. PMID: 25807675.
[2]Della Rocca G, Dogareschi T, Cecconet T, Buttera S, Spasiano A, Nadbath P, Angelini M, Galluzzo C, Marchesoni D. Coagulation assessment in normal pregnancy: thrombelastography with citrated non activated samples. Minerva anestesiologica.2012;78(12): 1357–64. PMID: 22858878.
[3]Gong JM, Shen Y, He YX. Reference Intervals of Routine Coagulation Assays During the Pregnancy and Puerperium Period. Journal of clinical laboratory analysis.2016;30(6): 912–7. DOI: 10.1002/jcla.21956.
[4]Teliga-Czajkowska J, Sienko J, Zareba-Szczudlik J, Malinowska-Polubiec A, Romejko-Wolniewicz E, Czajkowski K. Influence of Glycemic Control on Coagulation and Lipid Metabolism in Pregnancies Complicated by Prege stational and Gestational Diabetes Mellitus. Adv Exp Med Biol. 2019; 1176:81–88. DOI: 10.1007/5584_2019_382.
[5]Liu B, Xu Y, Voss C, Qiu FH, Zhao MZ, Liu YD, Nie J, Wang ZL. Altered protein expression in gestational diabetes mellitus placentas provides insight into insulin resistance and coagulation/fibrinolysis pathways. PloS one. 2012; 7(9): e44701. DOI: 10.1371/journal.pone.0044701. Epub 2012 Sep 7.
[6]Krikun G, Huang ST, Schatz F, Salafia C, Stocco C, Lockwood CJ. Thrombin activation of endometrial endothelial cells: a possible role in intrauterine growth restriction. Thrombosis and haemostasis.2007;97(2): 245–53. PMID: 17264954.
[7]Ovesen PG, Jensen DM, Damm P, Rasmussen S, Kesmodel US. Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes. a nation-wide study. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies.the International Society of Perinatal Obstet.2015; 28(14): 1720–4. DOI: 10.3109/14767058.2014.966677.
[8]Alsayegh F, Al-Jassar W, Wani S, Tahlak M, Albahar A, Al Kharusi L, Al-Tamimi H, El-Taher F, Mahmood N, Al-Zakwani I. Venous Thromboembolism Risk and Adequacy of Prophylaxis in High Risk Pregnancy in the Arabian Gulf. Curr Vasc Pharmacol.2016;14(4): 368–73. PMID: 26517701.
[9]Jarmuzek P, Wielgos M, Bomba-Opon D. Placental pathologic changes in gestational diabetes mellitus. Neuro endocrinology letters.2015;36(2): 101–5. PMID: 26071574.
[10]Liu BY, Jian YL, Zhong M, Yu YH, Wang Q, Zhang J. [Value of coagulation function and fibrinolytic system assessment in patients with gestational diabet es mellitus]. Nan Fang Yi Ke Da Xue Xue Bao.2007;27(1): 35–7. PMID: 17259140.
[11]American Diabetes A. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes–2018. Diabetes care.2018;41 Suppl 1: S13-s27. DOI: 10.2337/dc18-S002.
[12]Gorar S, Alioglu B, Ademoglu E, Uyar S, Bekdemir H, Candan Z, Saglam B, Koc G, Culha C, Aral Y. Is There a Tendency for Thrombosis in Gestational Diabetes Mellitus? Journal of laboratory physicians.2016; 8(2): 101–5. DOI: 10.4103/0974–2727.180790.
[13]Antony KM, Mansouri R, Arndt M, Rocky Hui SK, Jariwala P, Mcmullen VM, Teruya J, Aagaard K. Establishing thromboelastography with platelet-function analyzer reference ranges and other measures in healthy term pregnant women. American journal of perinatology.2015; 32(6): 545–54. DOI: 10.1055/s–0034–1396700.
[14]Zahr Eldeen F, Roll GR, Derosas C, Rao R, Khan MS, Gunson BK, Hodson J, Mergental H, Ferraz-Neto BH, Isaac J, Muiesan P, Mirza DF, Iqbal A, Perera MT. Preoperative Thromboelastography as a Sensitive Tool Predicting Those at Risk of Developing Early Hep atic Artery Thrombosis After Adult Liver Transplantation. Transplantation. 2016;100(11): 2382–90. DOI: 10.1097/TP.0000000000001395.
[15]Brill JB, Badiee J, Zander AL, Wallace JD, Lewis PR, Sise MJ, Bansal V, Shackford SR. The rate of deep vein thrombosis doubles in trauma patients with hypercoagulable thromboelastography. J Trauma Acute Care Surg. 2017; 83(3): 413–9. DOI: 10.1097/TA.0000000000001618.
[16]Sousa Gomes M, Guimaraes M, Montenegro N. Thrombolysis in pregnancy: a literature review. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2019; 32(14): 2418–28. DOI: 10.1080/14767058.2018.1434141.
[17]Chandra S, Tripathi AK, Mishra S, Amzarul M, Vaish AK. Physiological changes in hematological parameters during pregnancy. Indian journal of hematology & blood transfusion: an official journal of Indian Society of Hematology and Blood Transfusion. 2012; 28(3): 144–6. DOI: 10.1007/s12288–012–0175–6.
[18]Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med. 2008; 359(19): 2025–33. DOI: 10.1056/NEJMra0707993.
[19]Edlow JA, Caplan LR, O’brien K, Tibbles CD. Diagnosis of acute neurological emergencies in pregnant and post-partum women. Lancet Neurol. 2013; 12(2): 175–85. DOI: 10.1016/S1474–4422(12)70306-X.
[20]Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med.2005;143(10): 697–706. DOI: 10.7326/0003–4819–143–10–200511150–00006.
[21]Liang ZW, Gao WL, Feng LM. Clinical characteristics and prognosis of cerebral venous thrombosis in Chinese women during pregnancy and puerperium. Scientific reports. 2017;7:43866. DOI: 10.1038/srep43866.
[22]Devis P, Knuttinen MG. Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management. Cardiovasc Diagn Ther.2017;7 Suppl 3: S309-s19. DOI: 10.21037/cdt.2017.10.08.
[23]Abdel Gader AG, Khashoggi TY, Habib F, Awadallah SB. Haemostatic and cytokine changes in gestational diabetes mellitus. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology.2011;27(5): 356–60. DOI: 10.3109/09513590.2010.495241.
[24]Gumus, Ii, Kargili A, Karakurt F, Kasapoglu B, Derbent A, Kaygusuz I, Koca C, Sevgili S. Levels of thrombin activatable fibrinolysis inhibitor in gestational diabetes mellitus. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology.2013; 29(4): 327–30. DOI: 10.3109/09513590.2010.501884.
[25]Bleau N, Patenaude V, Abenhaim HA. Risk of Venous Thromboembolic Events in Pregnant Patients With Autoimmune Diseases: A Population-Based Study. Clin Appl Thromb Hemost. 2016; 22(3): 285–91. DOI: 10.1177/1076029614553023.
[26]Yang YY, Fang YH, Wang X, Zhang Y, Liu XJ, Yin ZZ. A retrospective cohort study of risk factors and pregnancy outcomes in 14,014 Chinese pregnant women. Medicine (Baltimore). 2018; 97(33): e11748. DOI: 10.1097/MD.0000000000011748.
[27]Ko GT, Yeung VT, Chan JC, Chow CC, Li JK, So WY, Tsang LW, Cockram CS. Plasma fibrinogen concentration in a Chinese population. Atherosclerosis. 1997; 131(2): 211–7. DOI: 10.1016/s0021–9150(97)06109–1.
[28]Bellart J, Gilabert R, Fontcuberta J, Carreras E, Miralles RM, Cabero L. Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetes. American journal of perinatology.1998;15(8): 479–86. DOI: 10.1055/s–2007–994069.
[29]Ambelu YA, Shiferaw MB, Abebe M, Enawgaw B. Prothrombin time, activated partial thromboplastin time and platelet counts of type II diabetes melli tus: a comparative study. J Diabetes Metab Disord. 2018;17(2): 117–21. DOI: 10.1007/s40200–018–0347–5.
[30]Kvasnicka J, Bendl J, Zivn J, Umlaufov¨¢ A, Maslowsk¨¢ H. [Changes in hemostasis and fibrinolysis in gestational diabetes]. Cas Lek Cesk.1996; 135(4): 106–10. PMID: 8625379.
[31]Aboud MR, Ma DD. Increased incidence of venous thrombosis in patients with shortened activated partial thromboplastin times and low ratios for activated protein C resistance. Clin Lab Haematol. 2001;23(6): 411–6. PMID: 11843891.
[32]Weng LC, Cushman M, Pankow JS, Basu S, Boerwinkle E, Folsom AR, Tang W. A genetic association study of activated partial thromboplastin time in European Americans and African Americans: the ARIC Study. Hum Mol Genet. 2015; 24(8): 2401–8. DOI: 10.1093/hmg/ddu732.
[33]Djelmis J, Ivanisevic M, Kurjak A, Mayer D. Hemostatic problems before, during and after delivery. J Perinat Med. 2001; 29(3): 241–6. DOI: 10.1515/JPM.2001.034.
[34]Wright JG, Cooper P, Astedt B, Lecander I, Wilde JT, Preston FE, Greaves M. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time. Br J Haematol.1988; 69(2): 253–8. DOI: 10.1111/j.1365–2141.1988.tb07630.x.
[35]Pelage JP, Fohlen A, Le Pennec V. [Role of arterial embolization in the management of postpartum hemorrhage]. J Gynecol Obstet Biol Reprod (Paris). 2014;43(10): 1063–82. DOI: 10.1016/j.jgyn.2014.10.002.
[36]Meier J. A new application for thrombelastography in pregnant women at term. Minerva anestesiologica.2012; 78(12): 1319–20. PMID: 23044742.
[37]Wang W, Wang AM, Huang XQ, Jiang W, Jia XN. Thromboelastography in women with pathological pregnancies: a preliminary study. Chin Med Sci J. 2014;29(1): 63–4. PMID: 24698684.